Friedman Billings downgrades Manor Care (HCR) to Market Perform
More News related to HCR
- PharMerica Names Geoffrey G. Meyers to Its Board of Directors
- Pre-Open Movers: MER, LVS Lower; RSYS, VIA Higher
- StreetInsider.com After-Hours Movers 11/01: LVS, LEAP Head Lower
- S&P Changes: POM, EGN, KCI
- Friedman Billings downgrades Manor Care (HCR) to Market Perform
More News related to Downgrades
- Icahn Outbids Penn National Gaming (PENN) On Bankrupt Fontainebleau Casino Project
- Overstock.com (OSTK) Dismisses Grant Thorton as Public Accounting Firm
- First Regional Bancorp (FRGB) Announces Adjustment in Taxes and Loan Losses
- NJ Attorney General Stuns TASER International (TASR) and OK's Electronic Control Devices
- Internap Network (INAP) to Amend Poison Pill
Friedman Billings downgrades Manor Care, Inc. (NYSE: HCR) from Outperform to Market Perform with a $67 price target.
Manor Care provides a range of healthcare services, including skilled nursing care, assisted living, post-acute medical and rehabilitation care, hospice care, home healthcare and rehabilitation therapy.
Related Categories
DowngradesStocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
